Contract 75A50121F33010
Seqirus Inc · Department Of Health And Human Services · September 21, 2021
Seqirus Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 21, 2021 for $21.34 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Holly Springs, NC. This is a task or delivery order issued under parent IDIQ 75A50118D00004. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 9, 2025.
Contract details
- PIID
- 75A50121F33010
- Parent IDIQ
- 75A50118D00004
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; R&D Administrative Expenses
- Place of performance
- Holly Springs, NC
- First action
- September 21, 2021
- Latest action
- October 9, 2025
Description
ACQUISITION OF INFLUENZA A(H2NX) VIRUS VACCINE CANDIDATE(S) AND CLINICAL TRIAL
Modification timeline
-
October 9, 2025Mod P00009 · Other Administrative Action$21.40M
-
September 21, 2021Base awardTHE PURPOSE OF THIS TASK ORDER IS TO PROCURE A INFLUENZA A(H2NX) VIRUS VACCINE CANDIDATE(S) AND CONDUCT CLINICAL TRIAL$35.02M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50121F33010?
Contract 75A50121F33010 is a federal contract awarded to Seqirus Inc by Department Of Health And Human Services on September 21, 2021 for $21.34 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75A50121F33010?
Seqirus Inc won contract 75A50121F33010 from Department Of Health And Human Services.
How much is contract 75A50121F33010 worth?
Contract 75A50121F33010 has obligated $21.34 million to date, with a total potential value of $21.40 million if all options are exercised.